Symptomatic Botulism caused by Clostridium botulinum serotype E
Drug | Drug Name | Drug Description |
---|---|---|
DB13897 | Equine Botulinum Neurotoxin E Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB13897 | Equine Botulinum Neurotoxin E Immune FAB2 | Botulinum neurotoxin type E | target |
Drug | Drug Name | Phase | Status | Count |
---|